EP2812451A4 - Procédés et compositions concernant des fusions de ros1 pour diagnostiquer et traiter le cancer - Google Patents

Procédés et compositions concernant des fusions de ros1 pour diagnostiquer et traiter le cancer

Info

Publication number
EP2812451A4
EP2812451A4 EP13746869.0A EP13746869A EP2812451A4 EP 2812451 A4 EP2812451 A4 EP 2812451A4 EP 13746869 A EP13746869 A EP 13746869A EP 2812451 A4 EP2812451 A4 EP 2812451A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
methods
treating cancer
compositions relating
ros1 fusions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13746869.0A
Other languages
German (de)
English (en)
Other versions
EP2812451A2 (fr
Inventor
David Hout
John Handshoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insight Genetics Inc
Original Assignee
Insight Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insight Genetics Inc filed Critical Insight Genetics Inc
Publication of EP2812451A2 publication Critical patent/EP2812451A2/fr
Publication of EP2812451A4 publication Critical patent/EP2812451A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP13746869.0A 2012-02-08 2013-02-08 Procédés et compositions concernant des fusions de ros1 pour diagnostiquer et traiter le cancer Withdrawn EP2812451A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261596720P 2012-02-08 2012-02-08
PCT/US2013/025345 WO2013119950A2 (fr) 2012-02-08 2013-02-08 Procédés et compositions concernant des fusions de ros1 pour diagnostiquer et traiter le cancer

Publications (2)

Publication Number Publication Date
EP2812451A2 EP2812451A2 (fr) 2014-12-17
EP2812451A4 true EP2812451A4 (fr) 2016-01-06

Family

ID=48948165

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13746869.0A Withdrawn EP2812451A4 (fr) 2012-02-08 2013-02-08 Procédés et compositions concernant des fusions de ros1 pour diagnostiquer et traiter le cancer

Country Status (5)

Country Link
EP (1) EP2812451A4 (fr)
JP (1) JP2015508644A (fr)
CN (1) CN104364391A (fr)
AU (1) AU2013216904A1 (fr)
WO (1) WO2013119950A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102300576B1 (ko) 2013-09-10 2021-09-08 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 절단된 선종성 결장 폴립증 (ａｐｃ) 단백질을 타겟화하는 치료제
TWI672141B (zh) * 2014-02-20 2019-09-21 美商醫科泰生技 投予ｒｏｓ１突變癌細胞之分子
CN106462669A (zh) * 2014-03-25 2017-02-22 奎斯特诊断投资股份有限公司 通过使用平均循环阈值的基因内差异表达(ide)检测基因融合
US10082496B2 (en) * 2014-09-10 2018-09-25 Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
CN107207471B (zh) 2014-12-02 2020-06-26 伊尼塔公司 用于治疗神经母细胞瘤的组合
CN104830989A (zh) * 2015-05-25 2015-08-12 上海允英医疗科技有限公司 一种用于ros1与多种基因发生融合突变的检测试剂盒
CN108138230B (zh) * 2015-07-21 2023-03-10 夸登特健康公司 用于捕获融合基因的锁核酸
AU2016370846B2 (en) 2015-12-18 2022-08-25 Ignyta, Inc. Combinations for the treatment of cancer
KR102718538B1 (ko) 2017-07-19 2024-10-21 이그니타, 인코포레이티드 엔트렉티닙을 포함하는 약학적 조성물
CN111225662B (zh) 2017-10-17 2022-11-22 伊尼塔公司 药物组合物和剂型
JP2022508651A (ja) * 2018-10-08 2022-01-19 レヴォリューション・メディスンズ，インコーポレイテッド 癌を処置するためのｓｈｐ２阻害剤組成物および方法
US20260085357A1 (en) * 2022-09-26 2026-03-26 Johnson Yiu-Nam Lau Compositions, systems, and methods for detection of ovarian cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007084631A2 (fr) * 2006-01-20 2007-07-26 Cell Signaling Technology, Inc. Translocation et kinase ros mutante dans un cancer du poumon non a petites cellules chez un etre humain
WO2011146945A2 (fr) * 2010-05-21 2011-11-24 Cell Signaling Technology, Inc. Kinase alk et ros dans le cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454994A1 (fr) * 2003-03-07 2004-09-08 Université de la Méditerranée Procédé stamdardisé et optimisé d'amplification en chaine par transcription inversé et amplification quantitative en temps réel pour la détection d'une pathologie résiduelle minime de la leucémie
US20100143918A1 (en) * 2007-01-19 2010-06-10 Cell Signaling Technology, Inc. Translocation and mutant ros kinase in human non-small cell lung carcinoma
EP3266795A1 (fr) * 2009-02-12 2018-01-10 Cell Signaling Technology, Inc. Méthode de détection d'un polynucléotide codant pour une fusion fig-ros
AU2010248782B2 (en) * 2009-05-15 2015-06-11 Insight Genetics, Inc. Methods and compositions relating to fusions of ALK for diagnosing and treating cancer
EP2586862B9 (fr) * 2010-06-22 2016-07-13 LSI Medience Corporation Procédé de détection d'un nouveau corps fusionné ros1

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007084631A2 (fr) * 2006-01-20 2007-07-26 Cell Signaling Technology, Inc. Translocation et kinase ros mutante dans un cancer du poumon non a petites cellules chez un etre humain
WO2011146945A2 (fr) * 2010-05-21 2011-11-24 Cell Signaling Technology, Inc. Kinase alk et ros dans le cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHENGUANG LI ET AL: "Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers", PLOS ONE, vol. 6, no. 11, 30 November 2011 (2011-11-30), pages e28204, XP055209333, DOI: 10.1371/journal.pone.0028204 *

Also Published As

Publication number Publication date
CN104364391A (zh) 2015-02-18
WO2013119950A3 (fr) 2014-11-13
JP2015508644A (ja) 2015-03-23
WO2013119950A2 (fr) 2013-08-15
AU2013216904A1 (en) 2014-08-28
EP2812451A2 (fr) 2014-12-17

Similar Documents

Publication Publication Date Title
IL289300A (en) Combination therapy for treating cancer
EP2812451A4 (fr) Procédés et compositions concernant des fusions de ros1 pour diagnostiquer et traiter le cancer
EP2925888A4 (fr) Compositions et procédés pour traiter le cancer
EP2771341A4 (fr) Nouvelles compositions et procédés pour traiter le cancer
EP2947990A4 (fr) Compositions et procédés pour traiter des organismes nuisibles
EP2861256A4 (fr) Compositions pour le traitement du cancer et leurs procédés de préparation
EP2909317A4 (fr) Procédés et compositions de traitement phytosanitaire
EP2665521A4 (fr) Compositions et procédés de traitement du cancer
EP2802675A4 (fr) Procédés de traitement de boue rouge
EP2904106A4 (fr) Compositions et procédés de ciblage de cellules stromales pour le traitement du cancer
EP2971280A4 (fr) Compositions et procédés de microréseaux de biocapteurs
PT2897620T (pt) Método de tratamento de cancro
IL238416A0 (en) Preparations and methods for the treatment of diseases caused by protein pathology
EP2914084A4 (fr) Compositions et procédés permettant de favoriser le développement des plantes
DK3292875T3 (en) Compositions and methods for treating diseases
EP2895606A4 (fr) Compositions et procédés de traitement de la sclérose latérale amyotrophique
EP2830661A4 (fr) Méthodes et compositions diagnostiques pour le traitement du cancer
EP2931324A4 (fr) Compositions et procédés de régénération tissulaire
EP2908865A4 (fr) Procédés de traitement utilisant un adénovirus
EP2921510A4 (fr) Composition de traitement de surface
EP2678685A4 (fr) Compositions et procédés pour le traitement de profilage de tumeur personnalisé
EP2897613A4 (fr) Compositions de traitement
LT2849760T (lt) Oligonukleotidų chelatinių kompleksų būdai
EP2849798A4 (fr) Compositions de polypeptide-complexe chélaté oligonucléotidique et procédés
EP2844258A4 (fr) Procédés et compositions pour traiter une infection bactérienne

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140905

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20151207

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101AFI20151201BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160715